Wrigley Billionaire Moves From Chewing Gum to Medical Marijuana
(Bloomberg) -- The scion of a family that made a fortune in chewing gum is moving into pot.
William Wrigley Jr. II, who helped orchestrate the sale of his family's business to Mars Inc. in 2008, led a $65 million investment round for Surterra Wellness, a medical cannabis startup in Georgia with licenses to operate in Florida and Texas. The funding brings the total raised so far to $100 million, according to Surterra.
Wrigley, 54, who left the gum and candy business after the sale, backs companies through a personal investment arm based in West Palm Beach, Florida. After an initial investment in Surterra in September, Wrigley is boosting his stake and assuming the role of chairman. Surterra is his first direct investment in the marijuana industry.
Wrigley, known as Beau, said he got into the industry mainly because of marijuana's medical benefits. He said he's tapping his experience with product distribution and brand-building to drive growth at Surterra. The cannabis company operates 10 medical dispensaries in Florida, including one in Miami Beach, and has a license to operate in the nascent Texas market.
“When I understood the massive benefits, it really changed my mind about the industry,” Wrigley said in an interview, his first public comments about the investment. “You don't see too many opportunities to have that kind of an impact in an industry that is being created from scratch.”
Wrigley, a billionaire whose great-grandfather founded Wrigley Co. in 1891, hasn't yet invested in the burgeoning recreational marijuana market, which hit the East Coast recently in Massachusetts. But he's watching closely as more states look to cash in on legal sales for adults of a drug that's still considered illegal by the federal government.
Dozens of states now allow medical marijuana use, and the FDA recently approved the first-ever cannabis-derived drug. Wrigley said the federal government will likely take more steps to loosen regulations. So far, the federal ban in the U.S. has mostly prevented banks and big institutional investors from taking part in the cannabis investment boom. As Canada prepares to legalize the drug for adult use in October, money is pouring across the border.
QuickTake: Marijuana legalization
Wrigley said Surterra plans to eventually participate in the domestic recreational market, which is forecast to surge above $5 billion this year. Currently, nine states have legalized the sale and consumption of marijuana by adults. When including medical sales, the U.S. market will hit $11 billion this year, according to a report by Arcview Market Research and BDS Analytics.
Despite some hesitation because of the federal ban, the transition of billions of dollars into the legal U.S. economy from the black market is drawing a lot interest from investors.
“Everyone seems to be in there because they think they're going to make tons of money,” Wrigley said. “Some will and some will be sorely surprised when they understand how complex it is.”
To contact the reporter on this story: Craig Giammona in New York at cgiammona@bloomberg.net
To contact the editors responsible for this story: Anne Riley Moffat at ariley17@bloomberg.net, Mark Schoifet
©2018 Bloomberg L.P.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.